CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 

Wright Current Income Fund - 25th anniversary

 
 
 
 
 
 
Tissue Regenix Group PLC Company Snapshot
Tissue Regenix Group plc, is a United Kingdom-based holding company. It is a regenerative medical devices company, which uses animal or human tissue to replace damaged or worn out parts of the human body. The Principal activity of the Company is exploitation of platform technologies in the field of tissues engineering and regenerative medicine. It focuses on developing a number of products, addressing a range of needs across multiple therapeutic areas, utilising its platform technology, dCell. The dCell process is used to create biological scaffolds by decellularising human or animal tissue. As of January 31, 2012, the dCell process has been used with human donor valves in over 140 patients. In November 2012, it has set up a subsidiary company in the United States, as part of its commercialization strategy for its dCELL technology platform.

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tissue Regenix Group PLC
  Stock Performance Chart for Tissue Regenix Group PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (8/15/2014): 25.38p
(Figures in Pounds Sterling)
1 Week 8.0%   13 Weeks 1.5%  
4 Weeks 3.6%   52 Weeks 157.0%  
 
Tissue Regenix Group PLC Key Data:
  Ticker: TRX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2014 Sales 6,000
(Year Ending Jan 2015).
Employees: 48
  Currency: Pounds Sterling Market Cap: 165,983,719
  Fiscal Yr Ends: January Shares Outstanding: 654,123,031
  Share Type: Ordinary Closely Held Shares: 295,707,015
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.